Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001363984-26-000004

Options or other derivatives

  • Chief Financial Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Maynard Ryan D Chief Financial Officer 2026-02-23 Grant or award · Stock Option (right to buy) +400,000 $5.75 $2,300,000 400,000 D
Loading xslF345X05/primarydocument.xml…